The medicalization of chronic disease and costs

Annual Review of Public Health

Volumn 33, Issue , 2012, Pages 409-423

  Thorpe, Kenneth E ^a   Philyaw, Meredith ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

Health care spending; Obesity; Prevalence

Indexed keywords

ANTIHYPERTENSIVE AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SEROTONIN UPTAKE INHIBITOR;

CHRONIC DISEASE; DEPRESSION; DIAGNOSTIC PROCEDURE; EVIDENCE BASED PRACTICE; HEALTH CARE COST; HEALTH SERVICE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LONGEVITY; MORBIDITY; OBESITY; PATIENT COUNSELING; PREVALENCE; PRIORITY JOURNAL; REVIEW; TREATMENT PLANNING;

CHRONIC DISEASE; HEALTH CARE COSTS; HUMANS; OBESITY; PREVALENCE; UNITED STATES;

EID: 84861394064     PISSN: 01637525     EISSN: 15452093     Source Type: Book Series    
DOI: 10.1146/annurev-publhealth-031811-124652     Document Type: Review

References (72)

1. Anderson G. 2010. Chronic Care: Making the Case for Ongoing Care. Princeton, NJ: Robert Wood Johnson Found. http://www.rwjf.org/files/research/ 50968chronic.care.chartbook.pdf
2. Anderson G, Horvath J. 2002. Chronic Conditions: Making the Case for Ongoing Care. Baltimore: Johns Hopkins Univ. Press
3. Anderson GF, Hussey PS, Frogner BK, Waters HR. 2005. Health spending in the United States and the rest of the industrialized world. Health Aff. (Millwood) 24:903-14
4. Arnst C. 2008. Behind rising health care costs. Bloomberg Businessweek, July 14
5. Axene DV, Doyle RL, van der Burch D. 1997. Analysis of Medically Unnecessary Inpatient Services. New York: Milliman & Robertson
6. Blumenthal D. 2001. Controlling health care expenditures. N. Engl. J. Med. 344:766-69
7. Bodenheimer T. 2005. High and rising health care costs. Part 3: The role of health care providers. Ann. Intern. Med. 142:996-1002
8. Brook RH. 1989. Practice guidelines and practicing medicine. Are they compatible? JAMA 262:3027-30
9. Brown JD, Monaco RM. 2004. Possible alternatives to the Medicare Trustees' long-term projections of health spending. Work. Pap., US Dep. Treas., Off. Econ. Policy, Washington, DC. http://www.treasury.gov/resource-center/ economic-policy/Documents/healthspending.pdf
10. Cent. Dis. Control Prev. 1984. Perspectives in disease prevention and health promotion smoking and cardiovascular disease. MMWR 32:677-79. http://www.cdc.gov/mmwr/preview/mmwrhtml/00000252.htm
11. Cent. Dis. Control Prev. 2009. Cigarette smoking among adults and trends in smoking cessation\United States, 2008. MMWR 58:1227-32. http://www.cdc.gov/ mmwr/preview/mmwrhtml/mm5844a2.htm
12. Cent. Dis. Control Prev. 2011. Detailed data for diagnosed diabetes. Tech. Work. Pap., US Dep. Treas., Off. Econ. Policy. http://www.treasury.gov/ resource-center/economic-policy/Documents/healthspending.pdf
13. Cent. Medicare Medicaid Serv. 2010. National health expenditures aggregate, per capital amounts, percent distribution, and average annual percent growth: selected calendar years 1960-2009. Natl. Health Expend. Data. https://www.cms.gov/nationalhealthexpenddata/downloads/tables.pdf
14. Chernew ME, Jacobson PD, Hofer TP, Aaronson KD, Fendrick AM. 2004. Barriers to constraining health care cost growth. Health Aff. (Millwood) 23:122-28
15. Congr. Budget Off. 2008. Technological Changes and the Growth of Health Spending. Washington, DC: Congr. Budget Off. Publ. No. 2764. http://www.cbo.gov/ftpdocs/89xx/doc8947/01-31-TechHealth.pdf
16. Congr. Budget Off. 2010. How does obesity in adults affect spending on health care? Econ. Budget Issue Brief. http://www.cbo.gov/ftpdocs/118xx/ doc11810/09-08-Obesity-brief.pdf
17. Cutler DM, Berndt ER. 2001. Medical Care Output and Productivity. Natl. Bur. Econ. Res. Vol. 62. Chicago: Univ. Chicago Press
18. Cutler DM, Long G, Berndt ER, Royer J, Fournier A-A, et al. 2007. The value of antihypertensive drugs: a perspective on medical innovation. Health Aff. 26:97-110
19. Cutler DM, McClellan M. 2001. Is technological change in medicine worth it? Health Aff. (Millwood) 20:11-29
20. Danzon PM, Pauly MV. 2001. Insurance and new technology: from hospital to drugstore. Health Aff. (Millwood) 20:86-100
21. Deyo RA, Nachemson A, Mirza SK. 2004. Spinal-fusion surgery\the case for restraint. N. Engl. J. Med. 350:722-26
22. Emanuel EJ, Young-Xu Y, Levinsky NG, Gazelle G, Saynina O, Ash AS. 2003. Chemotherapy use among Medicare beneficiaries at the end of life. Ann. Intern. Med. 138:639-43
23. Finkelstein A. 2007. The aggregate effects of health insurance: evidence from the introduction of Medicare. Q. J. Econ. 122:1-38
24. Fischer MA, Avorn J. 2004. Economic implications of evidence-based prescribing for hypertension: Can better care cost less? JAMA. 291; 1850-56
25. Ford ES, Ajani UA, Croft JB, Critchley JA, Labarthe DR, et al. 2007. Explaining the decrease in US deaths from coronary disease, 1980-2000. N. Engl. J. Med. 356:2388-98
26. Gelijns A, Rosenberg N. 1994. The dynamics of technological change in medicine. Health Aff. (Millwood) 13:28-46
27. Ginsburg PB. 2008. High and Rising Health Care Costs: Demystifying US Health Care Spending. Princeton, NJ: Robert Wood Johnson Found
28. Glass AG, Lacey JV Jr, Carreon JD, Hoover RN. 2007. Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status. J. Natl. Cancer Inst. 99:1152-61
29. Hartman M, Martin A, McDonnell P, Catlin A. 2009. National health spending in 2007: slower drug spending contributes to lowest rate of overall growth since 1998. Health Aff. (Millwood) 28:246-61
30. Howard DH, Thorpe KE, Busch SH. 2010. Understanding recent increases in chronic disease treatment rates: more disease or more detection? Health Econ. Policy Law 5:411-35
31. Huang ES, Basu A, O'Grady MJ, Capretta JC. 2009. Using clinical information to project federal health care spending. Health Aff. (Millwood) 28:w978-90
32. James W, Jackson-Leach R, Mhurchu CN, Kalamara E, Shayeghi M, et al. 2003. Overweight and obesity (high body mass index). In Comparative Quantification of Health Risks: Global and Regional Burden of Disease Attributable to Selected Major Risk Factors, ed. M Ezzati, AD Lopez, A Rodgers, CJL Murray, pp. 497-596. Geneva: World Health Organ.
33. Kaiser Family Found. 2007. How changes in medical technology affect health care costs. Snapshots: Health Care Costs. March: http://www.kff.org/ insurance/snapshot/chcm030807oth.cfm
34. Kaiser Family Found. 2009. Health Care Costs: A Primer. Menlo Park, CA: Kaiser Family Found. Publ. No. 7670-02. http://www.kff.org/insurance/upload/ 7670-02.pdf
35. Kenny SJ, Smith PJ, Goldschmid MG, Newman JM, Herman WH. 1993. Survey of physician practice behaviors related to diabetes mellitus in the U.S. Physician adherence to consensus recommendations. Diabetes Care 16:1507-10
36. Krantz MJ, Haugen SJ, Batal H, Long CS. 2005. Off-site percutaneous coronary intervention reduces hospital length of stay in vulnerable patients with acute myocardial infarction. Crit. Pathw. Cardiol. 4:127-30
37. Lakdawalla DN, Goldman DP, Shang B. 2005. The health and cost consequences of obesity among the future elderly. Health Aff. (Millwood) 24(Suppl. 2):W5R30-41
38. Lichtenberg FR. 1996. The effect of pharmaceutical utilization and innovation on hospitalization and mortality. Work. Pap. 5418, Natl. Bur. Econ. Res., Cambridge, MA
39. Lubitz J. 2005. Health, technology, and medical care spending. Health Aff. (Millwood) 24(Suppl. 2):W5R81-85
40. Ogden CL, Carroll MD. 2010. Prevalence of Overweight, Obesity and Extreme Obesity Among Adults: United States, Trends 1960-1962 through 2007-2008. Atlanta, GA: Natl. Cent. Health Stat., Cent. Dis. Control Prev. http://www.cdc.gov/nchs/data/hestat/obesity-adult-07-08/obesity-adult-07-08.pdf
41. Peden EA, Freeland MS. 1995. A historical analysis of medical spending growth, 1960-1993. Health Aff. (Millwood) 14:235-47
42. Reinhardt UE. 2003. Does the aging of the population really drive the demand for health care? Health Aff. (Millwood) 22:27-39
43. Rettig RA. 1994. Medical innovation duels cost containment. Health Aff. (Millwood) 13:7-27
44. Robinson JC. 1996. Decline in hospital utilization and cost inflation under managed care in California. JAMA 276:1060-64
45. Roehrig C, Miller G, Lake C, Bryant J. 2009. National health spending by medical condition, 1996-2005. Health Aff. (Millwood) 28:w358-67
46. Roehrig CS, Rousseau DM. 2011. The growth in cost per case explains far more of US health spending increases than rising disease prevalence. Health Aff. (Millwood) 30:1657-63
47. Rosenthal MB, Berndt ER, Donohue JM, Epstein AM, Frank RG. 2003. Demand Effects of Recent Changes in Prescription Drug Promotion. Menlo Park, CA: Kaiser Family Found. Publ. No. 6085. http://www.kff.org/rxdrugs/loader.cfm?url=/ commonspot/security/getfile.cfm&PageID=14380
48. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, et al. 2002. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288:321-33
49. Runge CF. 2007. Economic consequences of the obese. Diabetes 56:2668-72
50. Santerre RE. 2007. Tracking uninsurance and inflation in the U.S. health economy. Pravartak: J. Insur. Risk Manag. 3:79-89
51. Schneider EC, Leape LL, Weissman JS, Piana RN, Gatsonis C, Epstein AM. 2001. Racial differences in cardiac revascularization rates: Does "overuse" explain higher rates among white patients? Ann. Intern. Med. 135:328-37
52. Shactman D, Altman SH, Eilat E, Thorpe KE, Doonan M. 2003. The outlook for hospital spending. Health Aff. (Millwood) 22:12-26
53. Sleight P. 1993. Smoking and hypertension. Clin. Exp. Hypertens. 15:1181-92
54. Smith C, Cowan C, Sensenig A, Catlin A. 2005. Health spending growth slows in 2003. Health Aff. (Millwood) 24:185-94
55. Strunk BC, Ginsburg PB, Gabel JR. 2002. Tracking health care costs: growth accelerates again in 2001. Health Aff. (Millwood) Suppl. Web Exclus.:W299-310
56. Stuart B, Lloyd J, Zhao L, Kamal-Bahl S. 2008. Obesity, disease burden, and prescription spending by community-dwelling Medicare beneficiaries. Curr. Med. Res. Opin. 24:2377-87
57. Sturm R. 2002. The effects of obesity, smoking, and drinking on medical problems and costs. Health Aff. (Millwood) 21:245-53
58. Sullivan PW, Ghushchyan V, Ben-Joseph RH. 2008. The effect of obesity and cardiometabolic risk factors on expenditures and productivity in the United States. Obesity 16:2155-62
59. Swan J, Breen N, Graubard BI, McNeel TS, Blackman D, et al. 2010. Data and trends in cancer screening in the United States: results from the 2005 National Health Interview Survey. Cancer 116:4872-81
60. Tangka FK, Trogdon JG, Richardson LC, Howard D, Sabatino SA, Finkelstein EA. 2010. Cancer treatment cost in the United States: Has the burden shifted over time? Cancer 116:3477-84
61. Thorpe KE, Florence CS, Howard DH, Joski P. 2005. The rising prevalence of treated disease: effects on private health insurance spending. Health Aff. (Millwood) Suppl. Web Exclus.:W5-317-25
62. Thorpe KE, Ogden LL, Galactionova K. 2010. Chronic conditions account for rise in Medicare spending from 1987 to 2006. Health Aff. (Millwood) 29:718-24
63. Thorpe KE, Yang Z. 2011. Enrolling people with prediabetes ages 60-64 in a proven weight loss program could save medicare $7 billion or more. Health Aff. 30:1673-79
64. Thrall JH. 2005. Prevalence and costs of chronic disease in a health care system structured for treatment of acute illness. Radiology 235:9-12
65. Tosetti E, Moscone F. 2007. Health expenditure and income in the United States. Health Econ. 19:1385-403
66. Trasande L, Liu Y, Fryer G, Weitzman M. 2009. Effects of childhood obesity on hospital care and costs, 1999-2005. Health Aff. (Millwood) 28:w751-60
67. U.S. Census Bur. 2011. Health insurance historical tables. http://www.census.gov/hhes/www/hlthins/data/historical/index.html
68. van Baal PH, Polder JJ, de Wit GA, Hoogenveen RT, Feenstra TL, et al. 2008. Lifetime medical costs of obesity: prevention no cure for increasing health expenditure. PLoS Med. 5:e29
69. Wang SS, Sherman ME, Hildesheim A, Lacey JV Jr, Devesa S. 2004. Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000. Cancer 100:1035-44
70. Wang Y, Beydoun MA, Liang L, Caballero B, Kumanyika SK. 2008. Will all Americans become overweight or obese? Estimating the progression and cost of the US obesity epidemic. Obesity 16:2323-30
71. Wu SY, Green A. 2000. Projection of Chronic Illness Prevalence and Cost Inflation. Santa Monica, CA: RAND Health
72. Zook CJ, Moore FD. 1980. High-cost users of medical care. N. Engl. J. Med. 302:996-1002